Search results
Results From The WOW.Com Content Network
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. [7] The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan.
Genmab was founded as a European spin-off of American Biotech company Medarex in February 1999. [10] The company was acquired by Bristol Myers Squibb in 2009 for $2.4 billion, which included $300 million in debt, making the payment to Medarex $2.1 billion. [11] [12]
Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. [9] Daratumumab was granted breakthrough therapy drug status in 2013, for multiple myeloma.
Chairman, Genmab A/S , President of North America Pharmaceuticals for GlaxoSmithKline Deirdre P. Connelly (born in 1961) is a Puerto Rican business professional. [ 1 ] Connelly is Chairman of the Board of the European Biotech company Genmab A/S, member of the Boards of Macy’s Inc. and the Lincoln Financial Group.
Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands.
He was a du Pont Postdoctoral Fellow at the University of Illinois from 1950 to 1951. [3] He was the A. Barton Hepburn Professor of Organic Chemistry, Emeritus, joined the Princeton faculty in 1954 and transferred to emeritus status in 1997. In 2006 Taylor was named a Hero of Chemistry by the American Chemical Society. [4] He died on November ...
Princeton is a city in and the county seat of Bureau County, Illinois, United States. [2] The population was 7,832 at the 2020 census. Princeton is part of the Ottawa Micropolitan Statistical Area.
Muromonab-CD3 (brand name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant medication given to reduce acute rejection in people with organ transplants. [1] [2] It is a monoclonal antibody targeted at the CD3 receptor, [3] a membrane protein on the surface of T cells.